Sai Parenterals Limited (SAIPARENT) — Announcement | 28 May 2026

StockFin.ai

Try Free

Sai Parenterals Limited announced it received a USD 11 million purchase order at Rs.95 per share (Rs.104.50 crores) from PILL CORP, Philippines, for anti-TB products with a 10-year exclusive contract effective June 1, 2026, potentially extending beyond expiry with six-month notice. The order represents significant international revenue and long-term supply commitment.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SAIPARENT ✨ Ask AI About This

About Sai Parenterals Limited (SAIPARENT)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹2,126.13 Cr

View full SAIPARENT stock details →

📡 Get AI alerts when SAIPARENT files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SAIPARENT — Free

💡 Ask AI about this filing

"How does this announcement affect Sai Parenterals Limited's outlook?" "What did Sai Parenterals Limited announce on 28 May 2026?" "Is this positive or negative for SAIPARENT?"

Ask AI Free →

📊 More SAIPARENT filings

See all SAIPARENT filings →

🔥 Also filed on 28 May 2026

PRAJIND Praj Industries Limited Financial Results QUICKHEAL Quick Heal Technologies Limited Financial Results RADICO Radico Khaitan Limited Corporate Action RALLIS Rallis India Limited Annual Report REGAAL Regaal Resources Limited Financial Results RGL Renaissance Global Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when SAIPARENT files new disclosures

Track SAIPARENT filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SAIPARENT — Free

Free account · 2 AI queries/day